Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis&lt;SUBTITLE&gt;A Randomized Controlled Trial&lt;/SUBTITLE&gt;

T. Harris, Steven

doi:10.1001/jama.282.14.1344

Public

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Published in JAMA • Oct 13, 1999

Authors:

Steven T. Harris

Abstract

CONTEXT: Risedronate, a potent bisphosphonate, has been shown to be effective in the treatment of Paget disease of bone and other metabolic bone diseases but, to our knowledge, it has not been evaluated in the treatment of established postmenopausal osteoporosis. OBJECTIVE: To test the efficacy and ...

Subject

Medicine

Placebo

Osteoporosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!